Maze Therapeutics has set out plans for a $131 million IPO as the company prepares to start dosing its lead kidney drug in a phase 2 trial. The Bay Area-based biotech unveiled its ambition earlier ...
To find out if such bonded pairs can coordinate their behaviors and jointly solve problems, researchers at the University of Wyoming devised a special maze test. Each bird in this pair (the male ...
A pandemic is not inevitable, scientists say. But the outbreak has passed worrisome milestones in recent weeks, including cattle that may have been reinfected. By Apoorva Mandavilli Apoorva ...